
Cue Biopharma CUE
$ 0.86
14.04%
Quarterly report 2025-Q2
added 08-12-2025
Cue Biopharma EBITDA per Share 2011-2025 | CUE
Annual EBITDA per Share Cue Biopharma
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
-0.73 | -1.13 | -1.47 | -1.36 | -1.53 | -1.43 | -1.88 | -1.11 | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
-0.73 | -1.88 | -1.33 |
Quarterly EBITDA per Share Cue Biopharma
2025-Q2 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
-0.09 | - | -0.17 | -0.2 | - | -0.24 | -0.3 | -0.3 | - | -0.31 | -0.36 | -0.43 | - | -0.39 | -0.32 | -0.4 | - | -0.31 | -0.37 | -0.48 | - | -0.29 | -0.42 | -0.54 | - | -0.62 | -0.36 | -0.37 | - | -0.45 | -0.4 | -0.31 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
Maximum | Minimum | Average |
---|---|---|
-0.09 | -0.62 | -0.351 |
EBITDA per Share of other stocks in the Biotechnology industry
Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
---|---|---|---|---|---|---|
![]() |
Cellectis S.A.
CLLS
|
-2.92 | $ 4.3 | 12.57 % | $ 116 M | ![]() |
![]() |
Graybug Vision
GRAY
|
-8.47 | $ 0.44 | -11.23 % | $ 9.65 M | ![]() |
![]() |
AgeX Therapeutics
AGE
|
-9.04 K | $ 11.3 | -10.17 % | $ 12.2 K | - |
![]() |
Galera Therapeutics
GRTX
|
-0.37 | $ 0.14 | -32.59 % | $ 7.61 M | ![]() |
![]() |
Cyclerion Therapeutics
CYCN
|
-1.44 | $ 2.52 | -1.18 % | $ 6.35 M | ![]() |
![]() |
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
-2.62 | $ 4.37 | -1.58 % | $ 28.1 M | ![]() |
![]() |
Caladrius Biosciences
CLBS
|
-2.67 | $ 0.43 | -16.75 % | $ 25.8 M | ![]() |
![]() |
Sorrento Therapeutics
SRNE
|
-1.32 | $ 0.27 | -29.58 % | $ 126 M | ![]() |
![]() |
BeiGene, Ltd.
BGNE
|
-0.29 | $ 184.71 | 0.49 % | $ 251 B | ![]() |
![]() |
Midatech Pharma plc
MTP
|
-0.09 | $ 0.29 | -18.52 % | $ 27.3 M | ![]() |
![]() |
Aeterna Zentaris
AEZS
|
-0.08 | $ 5.72 | 5.93 % | $ 314 M | ![]() |
![]() |
ContraFect Corporation
CFRX
|
-124 | $ 1.47 | -5.16 % | $ 5.39 M | ![]() |
![]() |
Orchard Therapeutics plc
ORTX
|
-0.97 | $ 4.93 | 1.02 % | $ 90.8 M | ![]() |
![]() |
Advaxis
ADXS
|
-5.96 | $ 0.31 | -9.65 % | $ 45.9 M | ![]() |
![]() |
Heat Biologics, Inc.
HTBX
|
0.0497 | $ 3.93 | -5.76 % | $ 99.8 M | ![]() |
![]() |
La Jolla Pharmaceutical Company
LJPC
|
0.8 | $ 6.2 | - | $ 154 M | ![]() |
![]() |
Zymeworks
ZYME
|
-4.11 | $ 6.42 | - | $ 404 M | ![]() |
![]() |
Checkmate Pharmaceuticals
CMPI
|
-2.84 | $ 10.5 | - | $ 231 M | ![]() |
![]() |
Kadmon Holdings, Inc.
KDMN
|
-0.278 | $ 9.5 | - | $ 1.7 B | ![]() |
![]() |
BioDelivery Sciences International
BDSI
|
0.38 | $ 2.58 | -4.8 % | $ 255 M | ![]() |
![]() |
Zosano Pharma Corporation
ZSAN
|
-0.27 | $ 0.56 | 7.23 % | $ 2.72 M | ![]() |
![]() |
Ayala Pharmaceuticals
AYLA
|
-2.42 | $ 0.5 | - | $ 7.46 M | ![]() |
![]() |
Generation Bio Co.
GBIO
|
-2.07 | $ 6.33 | 1.61 % | $ 408 M | ![]() |
![]() |
Kiromic BioPharma
KRBP
|
-14.1 | $ 3.15 | 6.61 % | $ 3.08 M | ![]() |
![]() |
Acceleron Pharma Inc.
XLRN
|
-0.413 | $ 179.68 | - | $ 10.9 B | ![]() |
![]() |
Albireo Pharma
ALBO
|
-6.41 | $ 44.15 | -0.23 % | $ 916 M | ![]() |
![]() |
Stealth BioTherapeutics Corp
MITO
|
-0.07 | $ 0.32 | - | $ 23.9 M | ![]() |
![]() |
Trillium Therapeutics Inc.
TRIL
|
0.0792 | $ 18.44 | - | $ 1.94 B | ![]() |
![]() |
Kaleido Biosciences
KLDO
|
-2.04 | $ 0.29 | -3.69 % | $ 12.4 M | ![]() |
![]() |
Entasis Therapeutics Holdings
ETTX
|
-1.2 | $ 2.19 | - | $ 105 M | ![]() |
![]() |
Heron Therapeutics
HRTX
|
-0.06 | $ 1.35 | 2.27 % | $ 206 M | ![]() |
![]() |
ImmuCell Corporation
ICCC
|
0.13 | $ 6.59 | 2.17 % | $ 53.8 M | ![]() |
![]() |
Humanigen
HGEN
|
-0.77 | $ 0.04 | -81.12 % | $ 4.28 M | ![]() |
![]() |
Aptinyx
APTX
|
-0.92 | $ 0.06 | -39.0 % | $ 4.57 M | ![]() |
![]() |
Tyme Technologies
TYME
|
-0.203 | $ 0.31 | 8.07 % | $ 54 M | ![]() |
![]() |
Keros Therapeutics
KROS
|
-5.6 | $ 15.96 | 1.98 % | $ 598 M | ![]() |
![]() |
Forward Pharma A/S
FWP
|
-0.04 | $ 2.64 | -0.75 % | $ 18.7 M | ![]() |
![]() |
Krystal Biotech
KRYS
|
2.51 | $ 187.18 | 2.27 % | $ 5.35 B | ![]() |
![]() |
Kymera Therapeutics
KYMR
|
-3.39 | $ 56.29 | -1.11 % | $ 4.22 B | ![]() |
![]() |
Applied Genetic Technologies Corporation
AGTC
|
-0.36 | $ 0.39 | - | $ 26.5 M | ![]() |
![]() |
Celyad Oncology SA
CYAD
|
-1.69 | $ 0.47 | - | $ 12.5 M | ![]() |
![]() |
Brickell Biotech
BBI
|
-1.17 | $ 2.11 | -5.38 % | $ 6.06 M | ![]() |
![]() |
Genocea Biosciences
GNCA
|
-0.74 | $ 0.05 | -15.0 % | $ 3.04 M | ![]() |
![]() |
Codiak BioSciences
CDAK
|
-2.95 | $ 0.06 | -55.98 % | $ 2.15 M | ![]() |
![]() |
Concert Pharmaceuticals
CNCE
|
-2.21 | $ 8.37 | - | $ 401 M | ![]() |
![]() |
AIkido Pharma
AIKI
|
-1.85 | $ 3.17 | 1.93 % | $ 17.4 M | ![]() |
![]() |
Calithera Biosciences
CALA
|
-1.56 | $ 0.37 | -10.95 % | $ 876 K | ![]() |
![]() |
Forma Therapeutics Holdings
FMTX
|
-3.64 | $ 20.01 | - | $ 958 M | ![]() |
![]() |
Arena Pharmaceuticals
ARNA
|
-10.2 | $ 49.55 | -6.81 % | $ 3.04 B | ![]() |
![]() |
Sierra Oncology
SRRA
|
-7.11 | $ 54.89 | -0.05 % | $ 1.34 B | ![]() |